Related Experiment Video
Updated: May 26, 2026
04:13
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
Polypharmacy as a risk for fall occurrence in geriatric outpatients
Taro Kojima1, Masahiro Akishita, Tetsuro Nakamura
1Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Geriatrics & Gerontology International
|January 4, 2012
Summary
Polypharmacy, the use of multiple medications, significantly predicts falls in older adults. Taking five or more drugs increases fall risk in geriatric outpatients.
Area of Science:
- Geriatric Medicine
- Pharmacology
- Epidemiology
Background:
- Falls are a major concern in geriatric outpatients, leading to significant morbidity.
- Predicting fall risk is crucial for implementing preventive strategies in the elderly population.
Purpose of the Study:
- To identify predictors of falls in geriatric outpatients.
- To investigate the association between comorbidity, medication use, and falls.
Main Methods:
- A longitudinal observational study followed 172 geriatric outpatients for up to 2 years.
- Data collected included physical examination, clinical history, and medication profiles.
- Statistical analysis, including logistic regression, identified factors associated with falls.
Main Results:
- Older age, osteoporosis, number of comorbidities, and number of drugs were associated with falls.
- Polypharmacy (taking five or more drugs) was an independent predictor of falls.
- The number of medications was significantly associated with falls, even after accounting for other factors.
Conclusions:
- Polypharmacy is a significant risk factor for falls in geriatric outpatients.
- Further intervention studies are needed to establish causality between polypharmacy, comorbidity, and falls.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...